Aspek Bedah Saraf dari Kraniostenois Sindromik

• Main Author: Muhammad Arifin Parenrengi, NIDN. 9907013195
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Sanglah General Hospital in Colaboration to Indonesian Physician College of Surgeon Bali Indonesia 2018
• Subjects: R Medicine (General); RD Surgery
• Online Access: http://repository.unair.ac.id/88423/1/15%20-%20Aspek%20Bedah%20Saraf%20dari%20Kraniostenosis%20Sindromik_compressed.pdf; http://repository.unair.ac.id/88423/2/Neurosurgical%20Aspect%20In%20Syndromic.pdf; http://repository.unair.ac.id/88423/3/Aspek%20Bedah%20Saraf%20dari%20Kraniostenosis%20-%20full%20cover%20paper.pdf; http://repository.unair.ac.id/88423/
• Institution: Universitas Airlangga

Craniostenois is a congenital abnormality in the skull, caused by premature fusion of one or more sutures. The prevalence of craniostenois ranges from 3.1 to 6.06 per 10,000 births, 9% of which are syndromic craniostenois. Skull growth only occurs in normal sutures, if cranial growth is very limited, an increase in ICP can occur. Direct monitoring of ICP for at least 24 hours can help diagnose and make decision processes. Craniostenosis is a complex disorder and management requires coordinated effort from a craniofacial (CF) multidisciplinary team. Initial management is the evaluation of CF team members to determinate acute intervention, elective or just follow up. Acute neurosurgical intervention if an increase in ICP and visual impairment is found. If there is no acute action plan, an elective surgical plan is made, in the form of calvaria expansion to reduce ICP and frontoorbital advancement (FOA) to enlarge the orbital cavity in a certain age period. If there is no elective intervention plan, the patient is monitored to anticipate changes that lead to reevaluation of the management plan.